The aim of SysAFib is to integrate the existing sources of knowledge, using a systems medicine approach, into a focused decision support system, to determine which patients are good candidates for atrial ablation and which patients are at risk for arrhythmia recurrence.
Funding source:
ERA CoSysMed administration, funded in Norway via BIOTEK2021 program of the Norwegian Research Council
All partners:
- Simula Research Laboratory,
- Oslo University Hospital,
- Universiteit Maastricht,
- INRIA Sophia Antipolis,
- Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH),
- Center for Computational Medicine in Cardiology (Universitá della Svizzera italiana and CardioCentro Ticino)
Project leader:
Simula Research Laboratory